12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

bioMerieux, Thermo Fisher deal

bioMerieux and Thermo Fisher extended their non-exclusive 2004 deal to use Thermo Fisher's BRAHMS Procalcitonin (PCT) biomarker on bioMerieux's Vidas immunoassay. The immunoassay, which is performed on bioMerieux's mini Vidas and Vidas systems, is an enzyme-linked fluorescent immunoassay (ELFA) for the quantitative measurement of PCT. The partners...

Read the full 212 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >